Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies [NA]

View source ↗

Summary

A clinical study evaluating the safety and efficacy of BAFFR CAR-T therapy for relapsed/refractory B-cell malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies

Drugs mentioned

• BAFFR CAR-T therapy

Snippet

Sponsor: Donghua Zhang | Conditions: Relapsed/Refractory B-cell Malignancies | NA | Status: RECRUITING